nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—CNR1—muscle cancer	0.647	1	CbGaD
Dronabinol—CYP1A1—Dacarbazine—muscle cancer	0.0596	0.18	CbGbCtD
Dronabinol—ABCG2—Dactinomycin—muscle cancer	0.056	0.169	CbGbCtD
Dronabinol—ABCG2—Vincristine—muscle cancer	0.0345	0.104	CbGbCtD
Dronabinol—ABCG2—Etoposide—muscle cancer	0.0316	0.0953	CbGbCtD
Dronabinol—PTGS1—Etoposide—muscle cancer	0.0292	0.088	CbGbCtD
Dronabinol—ABCG2—Doxorubicin—muscle cancer	0.0216	0.065	CbGbCtD
Dronabinol—ABCG2—Methotrexate—muscle cancer	0.0209	0.063	CbGbCtD
Dronabinol—ABCB1—Dactinomycin—muscle cancer	0.0202	0.0609	CbGbCtD
Dronabinol—ABCB1—Vincristine—muscle cancer	0.0124	0.0375	CbGbCtD
Dronabinol—ABCB1—Etoposide—muscle cancer	0.0114	0.0344	CbGbCtD
Dronabinol—ABCB1—Doxorubicin—muscle cancer	0.00778	0.0234	CbGbCtD
Dronabinol—ABCB1—Methotrexate—muscle cancer	0.00753	0.0227	CbGbCtD
Dronabinol—CYP3A4—Vincristine—muscle cancer	0.00745	0.0225	CbGbCtD
Dronabinol—Nabilone—CNR1—muscle cancer	0.00739	1	CrCbGaD
Dronabinol—CYP3A4—Etoposide—muscle cancer	0.00683	0.0206	CbGbCtD
Dronabinol—CYP3A4—Doxorubicin—muscle cancer	0.00466	0.014	CbGbCtD
Dronabinol—Speech impairment NOS—Methotrexate—muscle cancer	0.000775	0.0566	CcSEcCtD
Dronabinol—Ataxia—Vincristine—muscle cancer	0.000238	0.0174	CcSEcCtD
Dronabinol—Speech disorder—Methotrexate—muscle cancer	0.000197	0.0144	CcSEcCtD
Dronabinol—Depression—Vincristine—muscle cancer	0.000195	0.0142	CcSEcCtD
Dronabinol—Sweating—Vincristine—muscle cancer	0.000187	0.0137	CcSEcCtD
Dronabinol—Flushing—Dactinomycin—muscle cancer	0.000182	0.0133	CcSEcCtD
Dronabinol—Chills—Dactinomycin—muscle cancer	0.000176	0.0128	CcSEcCtD
Dronabinol—Hallucination—Vincristine—muscle cancer	0.000174	0.0127	CcSEcCtD
Dronabinol—Vasodilation procedure—Doxorubicin—muscle cancer	0.000167	0.0122	CcSEcCtD
Dronabinol—Vasodilation—Doxorubicin—muscle cancer	0.000167	0.0122	CcSEcCtD
Dronabinol—Thinking abnormal—Doxorubicin—muscle cancer	0.00016	0.0117	CcSEcCtD
Dronabinol—Ill-defined disorder—Dactinomycin—muscle cancer	0.000158	0.0116	CcSEcCtD
Dronabinol—Malaise—Dactinomycin—muscle cancer	0.000154	0.0112	CcSEcCtD
Dronabinol—Myalgia—Dactinomycin—muscle cancer	0.000145	0.0106	CcSEcCtD
Dronabinol—Discomfort—Dactinomycin—muscle cancer	0.000144	0.0105	CcSEcCtD
Dronabinol—Anorexia—Dactinomycin—muscle cancer	0.000133	0.00969	CcSEcCtD
Dronabinol—Convulsion—Vincristine—muscle cancer	0.000132	0.00965	CcSEcCtD
Dronabinol—Flushing—Etoposide—muscle cancer	0.000132	0.00962	CcSEcCtD
Dronabinol—Myalgia—Vincristine—muscle cancer	0.00013	0.00948	CcSEcCtD
Dronabinol—Immune system disorder—Etoposide—muscle cancer	0.000128	0.00936	CcSEcCtD
Dronabinol—Chills—Etoposide—muscle cancer	0.000127	0.0093	CcSEcCtD
Dronabinol—Mental disability—Doxorubicin—muscle cancer	0.000127	0.00929	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000127	0.00927	CcSEcCtD
Dronabinol—Nervous system disorder—Vincristine—muscle cancer	0.000122	0.00891	CcSEcCtD
Dronabinol—Decreased appetite—Dactinomycin—muscle cancer	0.000121	0.00884	CcSEcCtD
Dronabinol—Hyperhidrosis—Vincristine—muscle cancer	0.00012	0.00878	CcSEcCtD
Dronabinol—Fatigue—Dactinomycin—muscle cancer	0.00012	0.00877	CcSEcCtD
Dronabinol—Anorexia—Vincristine—muscle cancer	0.000119	0.00866	CcSEcCtD
Dronabinol—Hypotension—Vincristine—muscle cancer	0.000116	0.00849	CcSEcCtD
Dronabinol—Ataxia—Methotrexate—muscle cancer	0.000116	0.00844	CcSEcCtD
Dronabinol—Feeling abnormal—Dactinomycin—muscle cancer	0.000115	0.00838	CcSEcCtD
Dronabinol—Ill-defined disorder—Etoposide—muscle cancer	0.000115	0.00837	CcSEcCtD
Dronabinol—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000114	0.00832	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000113	0.00828	CcSEcCtD
Dronabinol—Malaise—Etoposide—muscle cancer	0.000111	0.00813	CcSEcCtD
Dronabinol—Abdominal pain—Dactinomycin—muscle cancer	0.00011	0.00804	CcSEcCtD
Dronabinol—Decreased appetite—Vincristine—muscle cancer	0.000108	0.0079	CcSEcCtD
Dronabinol—Cough—Etoposide—muscle cancer	0.000108	0.00787	CcSEcCtD
Dronabinol—Fatigue—Vincristine—muscle cancer	0.000107	0.00783	CcSEcCtD
Dronabinol—Convulsion—Etoposide—muscle cancer	0.000107	0.00781	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000104	0.00763	CcSEcCtD
Dronabinol—Discomfort—Etoposide—muscle cancer	0.000104	0.00759	CcSEcCtD
Dronabinol—Hypersensitivity—Dactinomycin—muscle cancer	0.000103	0.00749	CcSEcCtD
Dronabinol—Gastrointestinal pain—Vincristine—muscle cancer	0.000102	0.00743	CcSEcCtD
Dronabinol—Confusional state—Etoposide—muscle cancer	0.000102	0.00742	CcSEcCtD
Dronabinol—Ataxia—Doxorubicin—muscle cancer	0.0001	0.0073	CcSEcCtD
Dronabinol—Asthenia—Dactinomycin—muscle cancer	9.99e-05	0.0073	CcSEcCtD
Dronabinol—Tachycardia—Etoposide—muscle cancer	9.84e-05	0.00718	CcSEcCtD
Dronabinol—Abdominal pain—Vincristine—muscle cancer	9.84e-05	0.00718	CcSEcCtD
Dronabinol—Skin disorder—Etoposide—muscle cancer	9.79e-05	0.00715	CcSEcCtD
Dronabinol—Hyperhidrosis—Etoposide—muscle cancer	9.75e-05	0.00712	CcSEcCtD
Dronabinol—Anorexia—Etoposide—muscle cancer	9.61e-05	0.00702	CcSEcCtD
Dronabinol—Diarrhoea—Dactinomycin—muscle cancer	9.53e-05	0.00696	CcSEcCtD
Dronabinol—Drowsiness—Methotrexate—muscle cancer	9.47e-05	0.00691	CcSEcCtD
Dronabinol—Depression—Methotrexate—muscle cancer	9.44e-05	0.00689	CcSEcCtD
Dronabinol—Hypotension—Etoposide—muscle cancer	9.42e-05	0.00688	CcSEcCtD
Dronabinol—Conjunctivitis—Methotrexate—muscle cancer	9.2e-05	0.00672	CcSEcCtD
Dronabinol—Hypersensitivity—Vincristine—muscle cancer	9.17e-05	0.00669	CcSEcCtD
Dronabinol—Sweating—Methotrexate—muscle cancer	9.08e-05	0.00663	CcSEcCtD
Dronabinol—Somnolence—Etoposide—muscle cancer	8.96e-05	0.00654	CcSEcCtD
Dronabinol—Asthenia—Vincristine—muscle cancer	8.93e-05	0.00652	CcSEcCtD
Dronabinol—Rash—Dactinomycin—muscle cancer	8.78e-05	0.00641	CcSEcCtD
Dronabinol—Decreased appetite—Etoposide—muscle cancer	8.76e-05	0.0064	CcSEcCtD
Dronabinol—Fatigue—Etoposide—muscle cancer	8.69e-05	0.00635	CcSEcCtD
Dronabinol—Diarrhoea—Vincristine—muscle cancer	8.51e-05	0.00622	CcSEcCtD
Dronabinol—Feeling abnormal—Etoposide—muscle cancer	8.31e-05	0.00607	CcSEcCtD
Dronabinol—Gastrointestinal pain—Etoposide—muscle cancer	8.24e-05	0.00602	CcSEcCtD
Dronabinol—Dizziness—Vincristine—muscle cancer	8.23e-05	0.00601	CcSEcCtD
Dronabinol—Drowsiness—Doxorubicin—muscle cancer	8.2e-05	0.00599	CcSEcCtD
Dronabinol—Abdominal pain—Etoposide—muscle cancer	7.97e-05	0.00582	CcSEcCtD
Dronabinol—Conjunctivitis—Doxorubicin—muscle cancer	7.97e-05	0.00582	CcSEcCtD
Dronabinol—Tinnitus—Methotrexate—muscle cancer	7.92e-05	0.00579	CcSEcCtD
Dronabinol—Sweating—Doxorubicin—muscle cancer	7.86e-05	0.00574	CcSEcCtD
Dronabinol—Rash—Vincristine—muscle cancer	7.85e-05	0.00573	CcSEcCtD
Dronabinol—Dermatitis—Vincristine—muscle cancer	7.84e-05	0.00572	CcSEcCtD
Dronabinol—Headache—Vincristine—muscle cancer	7.8e-05	0.00569	CcSEcCtD
Dronabinol—Sinusitis—Doxorubicin—muscle cancer	7.69e-05	0.00562	CcSEcCtD
Dronabinol—Immune system disorder—Methotrexate—muscle cancer	7.68e-05	0.00561	CcSEcCtD
Dronabinol—Chills—Methotrexate—muscle cancer	7.63e-05	0.00557	CcSEcCtD
Dronabinol—Hypersensitivity—Etoposide—muscle cancer	7.43e-05	0.00542	CcSEcCtD
Dronabinol—Rhinitis—Doxorubicin—muscle cancer	7.38e-05	0.00539	CcSEcCtD
Dronabinol—Asthenia—Etoposide—muscle cancer	7.23e-05	0.00528	CcSEcCtD
Dronabinol—Pruritus—Etoposide—muscle cancer	7.13e-05	0.00521	CcSEcCtD
Dronabinol—Diarrhoea—Etoposide—muscle cancer	6.9e-05	0.00504	CcSEcCtD
Dronabinol—Ill-defined disorder—Methotrexate—muscle cancer	6.86e-05	0.00501	CcSEcCtD
Dronabinol—Tinnitus—Doxorubicin—muscle cancer	6.86e-05	0.00501	CcSEcCtD
Dronabinol—Flushing—Doxorubicin—muscle cancer	6.83e-05	0.00499	CcSEcCtD
Dronabinol—Malaise—Methotrexate—muscle cancer	6.67e-05	0.00487	CcSEcCtD
Dronabinol—Dizziness—Etoposide—muscle cancer	6.67e-05	0.00487	CcSEcCtD
Dronabinol—Immune system disorder—Doxorubicin—muscle cancer	6.65e-05	0.00485	CcSEcCtD
Dronabinol—Chills—Doxorubicin—muscle cancer	6.6e-05	0.00482	CcSEcCtD
Dronabinol—Cough—Methotrexate—muscle cancer	6.46e-05	0.00471	CcSEcCtD
Dronabinol—Convulsion—Methotrexate—muscle cancer	6.41e-05	0.00468	CcSEcCtD
Dronabinol—Rash—Etoposide—muscle cancer	6.36e-05	0.00464	CcSEcCtD
Dronabinol—Dermatitis—Etoposide—muscle cancer	6.35e-05	0.00464	CcSEcCtD
Dronabinol—Headache—Etoposide—muscle cancer	6.32e-05	0.00461	CcSEcCtD
Dronabinol—Myalgia—Methotrexate—muscle cancer	6.3e-05	0.0046	CcSEcCtD
Dronabinol—Tension—Doxorubicin—muscle cancer	6.29e-05	0.00459	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	6.26e-05	0.00457	CcSEcCtD
Dronabinol—Discomfort—Methotrexate—muscle cancer	6.22e-05	0.00454	CcSEcCtD
Dronabinol—Nervousness—Doxorubicin—muscle cancer	6.22e-05	0.00454	CcSEcCtD
Dronabinol—Confusional state—Methotrexate—muscle cancer	6.09e-05	0.00445	CcSEcCtD
Dronabinol—Ill-defined disorder—Doxorubicin—muscle cancer	5.94e-05	0.00434	CcSEcCtD
Dronabinol—Nervous system disorder—Methotrexate—muscle cancer	5.92e-05	0.00432	CcSEcCtD
Dronabinol—Skin disorder—Methotrexate—muscle cancer	5.86e-05	0.00428	CcSEcCtD
Dronabinol—Hyperhidrosis—Methotrexate—muscle cancer	5.84e-05	0.00426	CcSEcCtD
Dronabinol—Malaise—Doxorubicin—muscle cancer	5.78e-05	0.00422	CcSEcCtD
Dronabinol—Anorexia—Methotrexate—muscle cancer	5.76e-05	0.0042	CcSEcCtD
Dronabinol—Palpitations—Doxorubicin—muscle cancer	5.66e-05	0.00413	CcSEcCtD
Dronabinol—Hypotension—Methotrexate—muscle cancer	5.64e-05	0.00412	CcSEcCtD
Dronabinol—Cough—Doxorubicin—muscle cancer	5.59e-05	0.00408	CcSEcCtD
Dronabinol—Convulsion—Doxorubicin—muscle cancer	5.55e-05	0.00405	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Methotrexate—muscle cancer	5.5e-05	0.00402	CcSEcCtD
Dronabinol—Myalgia—Doxorubicin—muscle cancer	5.45e-05	0.00398	CcSEcCtD
Dronabinol—Anxiety—Doxorubicin—muscle cancer	5.44e-05	0.00397	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	5.42e-05	0.00396	CcSEcCtD
Dronabinol—Discomfort—Doxorubicin—muscle cancer	5.39e-05	0.00393	CcSEcCtD
Dronabinol—Somnolence—Methotrexate—muscle cancer	5.37e-05	0.00392	CcSEcCtD
Dronabinol—Dry mouth—Doxorubicin—muscle cancer	5.33e-05	0.00389	CcSEcCtD
Dronabinol—Confusional state—Doxorubicin—muscle cancer	5.27e-05	0.00385	CcSEcCtD
Dronabinol—Decreased appetite—Methotrexate—muscle cancer	5.25e-05	0.00383	CcSEcCtD
Dronabinol—Fatigue—Methotrexate—muscle cancer	5.21e-05	0.0038	CcSEcCtD
Dronabinol—Nervous system disorder—Doxorubicin—muscle cancer	5.13e-05	0.00374	CcSEcCtD
Dronabinol—Tachycardia—Doxorubicin—muscle cancer	5.1e-05	0.00373	CcSEcCtD
Dronabinol—Skin disorder—Doxorubicin—muscle cancer	5.08e-05	0.00371	CcSEcCtD
Dronabinol—Hyperhidrosis—Doxorubicin—muscle cancer	5.05e-05	0.00369	CcSEcCtD
Dronabinol—Anorexia—Doxorubicin—muscle cancer	4.98e-05	0.00364	CcSEcCtD
Dronabinol—Feeling abnormal—Methotrexate—muscle cancer	4.98e-05	0.00363	CcSEcCtD
Dronabinol—Gastrointestinal pain—Methotrexate—muscle cancer	4.94e-05	0.00361	CcSEcCtD
Dronabinol—Hypotension—Doxorubicin—muscle cancer	4.89e-05	0.00357	CcSEcCtD
Dronabinol—Abdominal pain—Methotrexate—muscle cancer	4.77e-05	0.00349	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Doxorubicin—muscle cancer	4.76e-05	0.00348	CcSEcCtD
Dronabinol—Somnolence—Doxorubicin—muscle cancer	4.65e-05	0.00339	CcSEcCtD
Dronabinol—Decreased appetite—Doxorubicin—muscle cancer	4.54e-05	0.00332	CcSEcCtD
Dronabinol—Fatigue—Doxorubicin—muscle cancer	4.51e-05	0.00329	CcSEcCtD
Dronabinol—Hypersensitivity—Methotrexate—muscle cancer	4.45e-05	0.00325	CcSEcCtD
Dronabinol—Asthenia—Methotrexate—muscle cancer	4.33e-05	0.00316	CcSEcCtD
Dronabinol—Feeling abnormal—Doxorubicin—muscle cancer	4.31e-05	0.00315	CcSEcCtD
Dronabinol—Gastrointestinal pain—Doxorubicin—muscle cancer	4.28e-05	0.00312	CcSEcCtD
Dronabinol—Pruritus—Methotrexate—muscle cancer	4.27e-05	0.00312	CcSEcCtD
Dronabinol—Abdominal pain—Doxorubicin—muscle cancer	4.13e-05	0.00302	CcSEcCtD
Dronabinol—Diarrhoea—Methotrexate—muscle cancer	4.13e-05	0.00302	CcSEcCtD
Dronabinol—Dizziness—Methotrexate—muscle cancer	3.99e-05	0.00292	CcSEcCtD
Dronabinol—Hypersensitivity—Doxorubicin—muscle cancer	3.85e-05	0.00281	CcSEcCtD
Dronabinol—Rash—Methotrexate—muscle cancer	3.81e-05	0.00278	CcSEcCtD
Dronabinol—Dermatitis—Methotrexate—muscle cancer	3.8e-05	0.00278	CcSEcCtD
Dronabinol—Headache—Methotrexate—muscle cancer	3.78e-05	0.00276	CcSEcCtD
Dronabinol—Asthenia—Doxorubicin—muscle cancer	3.75e-05	0.00274	CcSEcCtD
Dronabinol—Pruritus—Doxorubicin—muscle cancer	3.7e-05	0.0027	CcSEcCtD
Dronabinol—Diarrhoea—Doxorubicin—muscle cancer	3.58e-05	0.00261	CcSEcCtD
Dronabinol—Dizziness—Doxorubicin—muscle cancer	3.46e-05	0.00252	CcSEcCtD
Dronabinol—Rash—Doxorubicin—muscle cancer	3.3e-05	0.00241	CcSEcCtD
Dronabinol—Dermatitis—Doxorubicin—muscle cancer	3.29e-05	0.0024	CcSEcCtD
Dronabinol—Headache—Doxorubicin—muscle cancer	3.28e-05	0.00239	CcSEcCtD
